Biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics: "best 3"

Ended Awarded Last action

Contract number
75F40120D00027
Awardee
Awarding agency
Task orders
2 $16,043,860 obligated

Award facts

Combined order value
  • $16,043,860 Current, with exercised options
  • $20,179,554 Potential, with all options
Last date to order 100% complete
IDV ceiling 32% used
$50,000,000.00
Maximum order
$50,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through September 2025.

Under the contracts, the prime contractor will leverage large-scale U.S. healthcare data as the primary source, including administrative claims data and electronic health records, to support the FDA's post-market surveillance of biologics. Specifically, the aim is to obtain new data sources covering tens of millions of patients directly from insurers, payers or providers. Data must be accessible through a distributed network potentially using the OMOP common data model, with full medical charts reviewable for biologics surveillance activities. The original solicitation sought these data sources to advance the FDA Center for Biologics Evaluation and Research's Biologics Effectiveness and Safety Initiative #3 through the multiple IDIQ contracts.

Task orders

Task order Ordering agency Obligated Awarded
Biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics 75F40121F19002 Food and Drug Administration $13,362,338
Biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics: "best 3" 75F40120F19001 Food and Drug Administration $2,681,522

Transactions

Action Obligated Date
Other Administrative Action P00002 · Add far clause 52.204-27 and IPP invoicing - biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics: "best 3" $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75F40120D00027?

75F40120D00027 was awarded to Iqvia Government Solutions Inc. by Food and Drug Administration (Department of Health and Human Services) on September 30, 2020.

How much is contract 75F40120D00027 worth?

Orders under 75F40120D00027 have obligated $16,043,860. Their combined potential value, with all options, is $20,179,554. 75F40120D00027's own ceiling is $50,000,000. A single order can be worth up to $50,000,000.

How many orders have been placed under contract 75F40120D00027?

2 orders have been placed under 75F40120D00027, the latest on September 30, 2021.

Who can order from contract 75F40120D00027?

75F40120D00027 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75F40120D00027 part of a contract vehicle?

Yes. 75F40120D00027 is part of BEST Initative - Data Sources For Surveillance of Biologics.

Was contract 75F40120D00027 competed?

The extent of competition for 75F40120D00027 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login